Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic keratoconjunctivitis.

C S Foster1, M Calonge

  • 1Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston 02114.

Ophthalmology
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

Atopic keratoconjunctivitis can cause severe vision loss due to complications like fibrosis and keratopathy. Successful treatment involves interdisciplinary strategies, including antihistamines and environmental controls.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer.

British journal of cancer·2014
Same author

Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.

Prostate cancer and prostatic diseases·2012
Same author

Atopic keratoconjunctivitis.

Ocular immunology and inflammation·2012
Same author

Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer.

British journal of cancer·2012
Same author

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

British journal of cancer·2012
Same author

Difluprednate for inflammatory eye disorders.

Drugs of today (Barcelona, Spain : 1998)·2011
Same journal

Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation/Loss in Eyes With Geographic Atrophy.

Ophthalmology·2026
Same journal

Access to Intravitreal Anti-VEGF Drugs in Persons with Medicare Advantage Compared with Medicare Fee-For-Service.

Ophthalmology·2026
Same journal

Re: Dones et al.: Emergency department use of ocular point-of-care ultrasound and its utility in diagnosis at a tertiary academic medical center (Ophthalmology. 2026;133:720-727).

Ophthalmology·2026
Same journal

Cataract Surgery and the Risk of Conversion from Dry to Neovascular Age-related Macular Degeneration in the IRIS© Registry.

Ophthalmology·2026
Same journal

Blunt Ocular Trauma from BB Gun Pellet: Long-Term Corneal Endothelial Changes.

Ophthalmology·2026
Same journal

Atypical Sebaceous Adenoma of the Caruncle.

Ophthalmology·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Allergy and Immunology

Background:

  • Atopic keratoconjunctivitis (AKC) is a severe ocular allergic disease.
  • AKC can lead to significant visual impairment and blindness.

Observation:

  • A 9-year retrospective study analyzed 45 patients with AKC.
  • The study focused on clinical presentation and severe complications.

Findings:

  • Subepithelial fibrosis (26 patients) and severe keratopathy (34 patients) were common.
  • Neovascularization (17 patients) and persistent epithelial defects (21 eyes) led to vision loss.

Implications:

  • Interdisciplinary therapeutic strategies are crucial for managing AKC.
  • Systemic antihistamine therapy and strict environmental controls are key to successful outcomes.